Arvind Kumar
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- Tuberculosis Research and Epidemiology
-
- Phytochemicals and Medicinal Plants
Papers in
-
- COVID-19 Clinical Research Studies 10
- Viral Infections and Vectors 9
- Antifungal resistance and susceptibility 8
- Surgery 50
- Infectious Diseases and Tuberculosis 10
- Congenital Diaphragmatic Hernia Studies 6
- Co-authors
- Naveet Wig (45 shared papers)Mahmood F. Mafee (4 shared papers)Prerna Garg (3 shared papers)Rajinder Parshad (4 shared papers)Umang Arora (3 shared papers)Subodh Kumar (3 shared papers)Anita Chakravarti (2 shared papers)Monika Matlani (2 shared papers)
- Journals
- Drug Discoveries & Therapeutics (6 papers)Diabetes & Metabolic Syndrome Clinical Research & Reviews (3 papers)Medicine Science and the Law (3 papers)Infectious Disorders - Drug Targets (2 papers)Journal of Medical Virology (2 papers)
- Partner nations
- IndiaUnited StatesBangladesh
In The Last Decade
Arvind Kumar
166 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 162
- Infectious Diseases 522
- Complementary and alternative medicine 206
- Otorhinolaryngology 101
- Neurology 342
- Surgery 623
Countries citing papers authored by Arvind Kumar
This map shows the geographic impact of Arvind Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arvind Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arvind Kumar more than expected).
Fields of papers citing papers by Arvind Kumar
This network shows the impact of papers produced by Arvind Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arvind Kumar. The network helps show where Arvind Kumar may publish in the future.
Co-authors
The 25 scholars most cited alongside Arvind Kumar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 194 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 265 | |
| 2 | 2000 | 155 | |
| 3 | 2004 | 121 | |
| 4 | 2020 | 103 | |
| 5 | 2021 | 88 | |
| 6 | 2008 | 80 | |
| 7 | 2005 | 69 | |
| 8 | 2022 | 65 | |
| 9 | 2000 | 54 | |
| 10 | Thoracoscopic management of thoracic duct injury: Is there a place for conservatism? | 2004 | 53 |
| 11 | 2012 | 52 | |
| 12 | 2022 | 52 | |
| 13 | Factors influencing wound infection following laparoscopic cholecystectomy. | 2003 | 50 |
| 14 | 2022 | 48 | |
| 15 | 2020 | 45 | |
| 16 | 1985 | 45 | |
| 17 | 2020 | 43 | |
| 18 | 2022 | 43 | |
| 19 | 1994 | 41 | |
| 20 | 2004 | 39 |
About Arvind Kumar
Arvind Kumar is a scholar working on Infectious Diseases, Surgery, Epidemiology, Emergency Medicine and Neurology, having authored 194 papers that have together received 2.6k indexed citations. Recurring topics across this work include COVID-19 and Mental Health (11 papers), COVID-19 Clinical Research Studies (10 papers), Infectious Diseases and Tuberculosis (10 papers), Viral Infections and Vectors (9 papers), Mosquito-borne diseases and control (8 papers), Antifungal resistance and susceptibility (8 papers), Long-Term Effects of COVID-19 (7 papers) and Congenital Diaphragmatic Hernia Studies (6 papers). The work is most often cited by research in Infectious Diseases (522 citations), Complementary and alternative medicine (206 citations), Otorhinolaryngology (101 citations), Neurology (342 citations) and Surgery (623 citations). Arvind Kumar has collaborated with scholars based in India, United States and Bangladesh. Frequent co-authors include Naveet Wig, Mahmood F. Mafee, Prerna Garg, Rajinder Parshad, Umang Arora, Subodh Kumar, Anita Chakravarti, Monika Matlani, Upendra Baitha and Piyush Ranjan. Their work appears in journals such as Drug Discoveries & Therapeutics, Diabetes & Metabolic Syndrome Clinical Research & Reviews, Medicine Science and the Law, Infectious Disorders - Drug Targets and Journal of Medical Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.